Susan Greenfield

Baroness Professor Susan Greenfield, CBE

CEO and Founder

Susan has over 40 years’ research experience in brain physiology, particularly on the mechanisms underlying Parkinson's and Alzheimer's diseases. Since 1976 she has published over 200 papers in peer-reviewed journals, collected 32 honorary degrees from UK and foreign universities and been awarded many prestigious honours for her work in neurodegeneration.

Susan has a DPhil in Pharmacology from the University of Oxford.

Paul Mayho

Paul Mayho

Chief Financial Officer

Paul has over 25 years’ experience in the Finance industry where he has been widely exposed to high growth, VC backed operations. Following training at Grant Thornton, Paul has gained roles of increasingly high-level responsibility and understanding from Financial Controller at Oxford Molecular to Financial Director at Synaptiq Limited to CFO at Neuro-Bio Ltd.

Paul has a BSc Management Sciences from the University of Manchester

Sara Garcia Ratés

Dr Sara Garcia Ratés

Director of Research

Sara has experience in research and development and subsequent expertise relating to the nicotinic receptor – a main focus for Neuro-Bio. She started her career as a postdoctoral researcher exploring novel approaches to neurodegeneration at Oxford University and has continued this work while transitioning from academia to private sector.

Sara has a PhD in Research, Development and Drug Control from the University of Barcelona.

Paul Morrill

Paul Morrill

Lab Director

Paul’s experience lies within cellular and molecular biology, in conducting immunological and biochemical investigative research.

Paul has a BSc (Hons) in Biology from The University of Southampton.